Opportunities to Improve Outcomes of Graft-Versus-Host Disease in Solid Organ Transplantation

Abstract

Keywords

systems health quality performance improvement graft-versus-host disease solid-organ transplantation clinical outcomes

Get full access to this article

View all access options for this article.

References

Ganoza

Mazariegos

Khanna

. Current status of graft-versus-host disease after intestinal transplantation. Curr Opin Organ Transplant. 2019;24(2):199‐206. doi: 10.1097/MOT.0000000000000624

Williams

Thomas

Paner

, et al. Can donor-derived cell-free DNA detect graft-versus-host disease in solid organ transplantation: A case report. Transplant Proc. 2022;54(1):176‐179. doi: 10.1016/j.transproceed.2021.11.014

Lewis

Glehn-Ponsirenas

Gulbahce

, et al. High levels of donor-derived cell-free DNA in a case of graft-versus-host-disease following liver transplantation. Am J Transplant. 2022;22(3):973‐976. doi: 10.1111/ajt.16894

Ruggiu

Cuccuini

Mokhtari

, et al. Case report: Central nervous system involvement of human graft versus host disease: Report of 7 cases and a review of literature. Medicine (Baltimore). 2017;96(42):e8303. doi: 10.1097/MD.0000000000008303

Chang

Sageshima

Ciancio

, et al. Successful treatment for graft-versus-host disease after pancreas transplantation. Clin Transplant. 2014;28(2):217‐222. doi: 10.1111/ctr.12300

Jacobs

Olson

Ferreira

, et al. The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation. Am J Transplant. 2020;20(2):589‐592. doi: 10.1111/ajt.15579